A drug to treat advanced prostate cancer should be given to patients on the NHS, a health watchdog has said.
Abirateron, marketed as Zytiga, can extend the lives of late-stage cancer sufferers by more than three months.
The National Institute for Health and Clinical Excellence (Nice) revised its recommendations after fresh information from manufacturer Janssen, and the new draft guidance was welcomed by experts.
More top news
Butterflies and nerves of steel were behind the images shared and seen by millions across the globe.
The Duke and Duchess of Sussex thanked everyone who took part in the celebrations on Saturday, Kensington Palace said.
Established in 1913, the flower show has become one of the world’s biggest showcases for horticultural excellence.